Kupriyanov V V, Lakomkin V L, Korchazhkina O V, Stepanov V A, Kapelko V I
Institute of Experimental Cardiology, National Cardiology Research Centre, Moscow U.S.S.R.
Biochim Biophys Acta. 1991 Jul 5;1058(3):386-99. doi: 10.1016/s0005-2728(05)80135-5.
In order to investigate the potential role of cytosolic phosphates ([ATP], [ADP] and [Pi]) in the integration of mitochondrial respiration and mechanical function in the perfused heart, inhibition of the substrate end of the respiratory chain by amytal has been employed. A stepwise increase in amytal concentration (from 0.2 to 1.2 mM) resulted in the progressive abolition of the cardiac oxygen consumption, rate (VO2) in hearts oxidizing pyruvate (5 mM). The inhibition curve for VO2 was S-shaped, with K0.5 = 1.1 mM, and independent of the initial VO2 values varied by coronary flow and isoproterenol (Iso) addition. ADP-stimulated respiration of isolated mitochondria (malate + pyruvate) was twice as sensitive to amytal inhibition, whereas state 2 respiration (before ADP addition) had the same sensitivity as cardiac VO2. Decrease in VO2 was followed by a decline in phosphocreatine (PCr) content and augmentation of Pi at nearly constant ATP level and intracellular pH as assessed by the 31P-NMR method. These changes were associated with an elevation of cytosolic free [ADP] and a reduction of the [ATP]/[ADP] ratio and ATP affinity calculated from creatine kinase equilibrium. Concomitantly, pressure-rate product (PRP), maximal rates of contraction and relaxation fell down and the end diastolic pressure (EDP) rose at all initial loads. Amytal-inhibited hearts retained the capability to respond to Iso stimulation (0.1 microM, about 50% enhancement of PRP) even at 1 mM amytal, but their response to elevation of coronary flow was greatly diminished. Alterations in the PRP value induced by the inhibitor at a fixed coronary flow correlated negatively with cytosolic [ADP] and [Pi], and positively with [ATP]/[ADP] and A(ATP). In contrast, EDP correlated with all these parameters in the opposite manner. However, when PRP was varied by coronary flow in the absence of the inhibitor or at its fixed concentrations, such correlations were absent. These data imply that cytosolic phosphates can serve as a feedback between energy production and utilization when the control point(s) is (are) at the mitochondria. In contrast, other regulatory mechanisms should be involved when control is distributed among different steps located both in energy producing and utilizing systems.
为了研究胞质磷酸盐([ATP]、[ADP]和[Pi])在灌注心脏中线粒体呼吸与机械功能整合中的潜在作用,采用了阿米妥抑制呼吸链底物端的方法。阿米妥浓度逐步增加(从0.2 mM增至1.2 mM)导致氧化丙酮酸(5 mM)的心脏耗氧率(VO2)逐渐降低。VO2的抑制曲线呈S形,K0.5 = 1.1 mM,且与初始VO2值无关,初始VO2值因冠脉流量和添加异丙肾上腺素(Iso)而变化。分离线粒体(苹果酸 + 丙酮酸)的ADP刺激呼吸对阿米妥抑制的敏感性是心脏VO2的两倍,而状态2呼吸(添加ADP之前)与心脏VO2具有相同的敏感性。通过31P-NMR方法评估,VO2降低后,磷酸肌酸(PCr)含量下降,Pi增加,而ATP水平和细胞内pH几乎保持恒定。这些变化伴随着胞质游离[ADP]升高,以及由肌酸激酶平衡计算得出的[ATP]/[ADP]比值和ATP亲和力降低。同时,在所有初始负荷下,压力 - 速率乘积(PRP)、最大收缩和舒张速率下降,舒张末期压力(EDP)升高。即使在1 mM阿米妥存在的情况下,阿米妥抑制的心脏仍保留对Iso刺激(0.1 μM,PRP约增强50%)的反应能力,但它们对冠脉流量增加的反应大大减弱。在固定冠脉流量下,抑制剂诱导的PRP值变化与胞质[ADP]和[Pi]呈负相关,与[ATP]/[ADP]和A(ATP)呈正相关。相反,EDP与所有这些参数的相关性则相反。然而,当在无抑制剂或其固定浓度下通过冠脉流量改变PRP时,不存在这种相关性。这些数据表明,当控制点位于线粒体时,胞质磷酸盐可作为能量产生与利用之间的反馈。相反,当控制分布于能量产生和利用系统的不同步骤时,应涉及其他调节机制。